Quantitative and volumetric European association for the study of the liver and response evaluation criteria in solid tumors measurements: Feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization

Journal of Vascular and Interventional Radiology

Volumn 23, Issue 12, 2012, Pages 1629-1637

  Lin, Mingde ^a   Pellerin, Olivier ^b   Bhagat, Nikhil ^b   Rao, Pramod P ^b   Loffroy, Romaric ^b   Ardon, Roberto ^c   Mory, Benoit ^c   Reyes, Diane K ^b   Geschwind, Jean François ^b  

^a PHILIPS RESEARCH LABORATORIES   (Netherlands)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c PHILIPS RESEARCH LABORATORIES   (Germany)

Author keywords

3D; DEB; drug eluting beads; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; modified Response Evaluation Criteria in Solid Tumors; mRECIST; qEASL; quantitative EASL; RECIST; Response Evaluation Criteria in Solid Tumors; three dimensional; volumetric RECIST; vRECIST

Indexed keywords

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; FEASIBILITY STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LIVER; LIVER CELL CARCINOMA; MALE; MEASUREMENT; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING; TREATMENT RESPONSE; TUMOR VOLUME; VOLUMETRY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATTERN RECOGNITION, AUTOMATED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOFTWARE; SOFTWARE VALIDATION; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84870010695     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2012.08.028     Document Type: Article

References (38)

1. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
2. C.H. Lee, L. Braga, R.O.P. de Campos, and R.C. Semelka Hepatic tumor response evaluation by MRI NMR Biomed 24 2010 721 733
3. I.R. Kamel, E. Liapi, D.K. Reyes, M. Zahurak, D.A. Bluemke, and J.-F.H. Geschwind Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging Radiology 250 2009 466 473
4. A.B. Miller, B. Hoogstraten, M. Staquet, and A. Winkler Reporting results of cancer treatment Cancer 47 1981 207 214
5. J. Bruix, M. Sherman, and J.M. Llovet Clinical management of hepatocellular carcinoma. conclusions of the Barcelona-2000 EASL. Conference. J Hepatol 35 2001 421 430
6. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
7. H.K. Lim, and J.K. Han Hepatocellular carcinoma: evaluation of therapeutic response to interventional procedures Abdom Imaging 27 2002 168 179
8. J. Edeline, E. Boucher, and Y. Rolland Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma Cancer 118 2012 147 156
9. D.B. Brown, J.E. Gould, and D.A. Gervais Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria J Vasc Interv Radiol 20 2009 S425 S434
10. D.K. Reyes, J.A. Vossen, and I.R. Kamel Single-center phase II Trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States Cancer J 15 2009 526 532
11. Gasnier A, Ardon R, Ciofolo-Veit C, Leen E, Correas JM. Assessing tumour vascularity with 3D contrast-enhanced ultrasound: a new semi-automated segmentation framework. Paper presented at Biomedical Imaging: From Nano to Macro, 2010. IEEE International Symposium. April 14, 2010; Rotterdam, The Netherlands.
12. Mory B, Ardon R, Yezzi AJ, Thiran J-P. Non-Euclidean image-adaptive radial basis functions for 3D interactive segmentation. Paper presented at Twelfth IEEE International Conference on Computer Vision (ICCV). September 27, 2009; Kyoto, Japan.
13. Pellerin O, Lin M, Bhagat N, Ardon R, Mory B, Geschwind J-F. Comparison of semi-automatic volumetric VX2 hepatic tumor segmentation from cone beam CT and multi-detector CT with histology in rabbit models. Acad Radiol 2012. [Epub ahead of print Sep 1, 2012]
14. S. Kim, L. Mannelli, and C.H. Hajdu Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction J Magn Reson Imaging 31 2010 348 355
15. J.-S. Yu, and N.M. Rofsky Dynamic subtraction MR imaging of the liver: advantages and pitfalls AJR Am J Roentgenol 180 2003 1351 1357
16. S. Bonekamp, P. Jolepalem, M. Lazo, M.A. Gulsun, A.P. Kiraly, and I.R. Kamel Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data Radiology 260 2011 752 761
17. M.S. Galizia, H.G. Töre, H. Chalian, R. McCarthy, R. Salem, and V. Yaghmai MDCT necrosis quantification in the assessment of hepatocellular carcinoma response to yttrium 90 radioembolization therapy: comparison of two-dimensional and volumetric techniques Acad Radiol 19 2012 48 54
18. S. Suzuki, I. Yamaguchi, T. Kidouchi, A. Yamamoto, T. Masumoto, and Y. Ozaki Evaluation of effective dose during abdominal three-dimensional imaging for three flat-panel-detector angiography systems Cardiovasc Intervent Radiol 34 2011 376 382
19. A.L. Belton, S. Saini, K. Liebermann, G.W. Boland, and E.F. Halpern Tumour size measurement in an oncology clinical trial: comparison between off-site and on-site measurements Clin Radiol 58 2003 311 314
20. N.A. Obuchowski How many observers are needed in clinical studies of medical imaging? AJR Am J Roentgenol 182 2004 867 869
21. L. Bornemann, J.-M. Kuhnigk, and V. Dicken New tools for computer assistance in thoracic CT, part 2. therapy monitoring of pulmonary metastases. Radiographics 25 2005 841 848
22. F. Cademartiri, G. Luccichenti, and E. Maffei Imaging for oncologic staging and follow-up: review of current methods and novel approaches Acta Biomed 79 2008 85 91
23. L.N. Tran, M.S. Brown, and J.G. Goldin Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography Acad Radiol 11 2004 1355 1360
24. S.D. Curran, A.U. Muellner, and L.H. Schwartz Imaging response assessment in oncology. Cancer Imaging 6 Spec No A 2006 S126 130
25. M. Fabel, J. Biederer, and A. Jochens Semi-automated volumetric analysis of artificial lymph nodes in a phantom study Eur J Radiol 80 2008 e451 e457
26. S.J. Gwyther, and L.H. Schwartz How to assess anti-tumour efficacy by imaging techniques Eur J Cancer 44 2008 39 45
27. M. Baghi, S. Bisdas, and K. Engels Prognostic relevance of volumetric analysis in tumour specimens of hypopharyngeal cancer Clin Otolaryngol 32 2007 372 377
28. A.J. Beer, H.A. Wieder, and F. Lordick Adenocarcinomas of esophagogastric junction: multi-detector row CT to evaluate early response to neoadjuvant chemotherapy Radiology 239 2006 472 480
29. S. Lee, S. Kim, and J. Lee Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer Abdom Imaging 34 2009 430 440
30. B. Zhao, L.P. James, and C.S. Moskowitz Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer Radiology 252 2009 263 272
31. G.B. van den Broek, C.R.N. Rasch, and F.A. Pameijer Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma Cancer 101 2004 1809 1817
32. F.H. Miller, A.L. Keppke, and D. Reddy Response of liver metastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET AJR Am J Roentgenol 188 2007 776 783
33. D. Spira, M. Fenchel, and U.M. Lauer Comparison of different tumor response criteria in patients with hepatocellular carcinoma after systemic therapy with the multikinase inhibitor sorafenib Acad Radiol 18 2011 89 96
34. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
35. S. Keil, C. Plumhans, and F.F. Behrendt Semi-automated quantification of hepatic lesions in a phantom Invest Radiol 44 2009 82 88
36. A. Forner, C. Ayuso, and M. Varela Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma Cancer 115 2009 616 623
37. W.L. Monsky, I. Kim, and S. Loh Semiautomated segmentation for volumetric analysis of intratumoral ethiodol uptake and subsequent tumor necrosis after chemoembolization AJR Am J Roentgenol 195 2010 1220 1230
38. J.H. Shim, H.C. Lee, and S.-O. Kim Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models Radiology 262 2012 708 718